Evidence map›Paper›PMID 26168033›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2015

Differential Regulation of ERK1/2 and mTORC1 Through T1R1/T1R3 in MIN6 Cells.

Eric M Wauson, Marcy L Guerra, Julia Dyachok, Kathleen McGlynn, Jennifer Giles, Elliott M Ross, Melanie H Cobb

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Heterotrimeric GThe Journal of biological chemistry · 2020
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Methionine Regulates mTORC1 via the T1R1/T1R3-PLCβ-CaInternational journal of molecular sciences · 2016
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Eric M WausonDepartment of Pharmacology (E.M.W., M.L.G., J.D., K.M., E.M.R., M.H.C.) and the Green Center for Systems Biology (J.D., E.M.R.), University of Texas Southwestern Medical Center, Dallas, Texas 75390-9041; and Department of Physiology and Pharmacology (E.M.W., J.G.), Des Moines University, Des Moines, Iowa 50312.
Marcy L GuerraDepartment of Pharmacology (E.M.W., M.L.G., J.D., K.M., E.M.R., M.H.C.) and the Green Center for Systems Biology (J.D., E.M.R.), University of Texas Southwestern Medical Center, Dallas, Texas 75390-9041; and Department of Physiology and Pharmacology (E.M.W., J.G.), Des Moines University, Des Moines, Iowa 50312.
Julia DyachokDepartment of Pharmacology (E.M.W., M.L.G., J.D., K.M., E.M.R., M.H.C.) and the Green Center for Systems Biology (J.D., E.M.R.), University of Texas Southwestern Medical Center, Dallas, Texas 75390-9041; and Department of Physiology and Pharmacology (E.M.W., J.G.), Des Moines University, Des Moines, Iowa 50312.
Kathleen McGlynnDepartment of Pharmacology (E.M.W., M.L.G., J.D., K.M., E.M.R., M.H.C.) and the Green Center for Systems Biology (J.D., E.M.R.), University of Texas Southwestern Medical Center, Dallas, Texas 75390-9041; and Department of Physiology and Pharmacology (E.M.W., J.G.), Des Moines University, Des Moines, Iowa 50312.
Jennifer GilesDepartment of Pharmacology (E.M.W., M.L.G., J.D., K.M., E.M.R., M.H.C.) and the Green Center for Systems Biology (J.D., E.M.R.), University of Texas Southwestern Medical Center, Dallas, Texas 75390-9041; and Department of Physiology and Pharmacology (E.M.W., J.G.), Des Moines University, Des Moines, Iowa 50312.
Elliott M RossDepartment of Pharmacology (E.M.W., M.L.G., J.D., K.M., E.M.R., M.H.C.) and the Green Center for Systems Biology (J.D., E.M.R.), University of Texas Southwestern Medical Center, Dallas, Texas 75390-9041; and Department of Physiology and Pharmacology (E.M.W., J.G.), Des Moines University, Des Moines, Iowa 50312.
Melanie H CobbDepartment of Pharmacology (E.M.W., M.L.G., J.D., K.M., E.M.R., M.H.C.) and the Green Center for Systems Biology (J.D., E.M.R.), University of Texas Southwestern Medical Center, Dallas, Texas 75390-9041; and Department of Physiology and Pharmacology (E.M.W., J.G.), Des Moines University, Des Moines, Iowa 50312.
The University of Texas Southwestern Medical Center · USCenter for Systems Biology · USDes Moines University · US

Funding

G Protein-Coupled Receptors-Structure and RegulationR01GM030355 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI ROSS, ELLIOTT M · 1985 to 2015
$5.0M
MAP Kinse in Islet FunctionR01DK055310 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI COBB, MELANIE H. · 1998 to 2014
$3.4M
NIDDK NIH HHS DK55310NIDDK NIH HHS R01 DK055310NIGMS NIH HHS R01 GM030355
6 · The paper itself

Abstract

The MAPKs ERK1/2 respond to nutrients and other insulin secretagogues in pancreatic β-cells and mediate nutrient-dependent insulin gene transcription. Nutrients also stimulate the mechanistic target of rapamycin complex 1 (mTORC1) to regulate protein synthesis. We showed previously that activation of both ERK1/2 and mTORC1 in the MIN6 pancreatic β-cell-derived line by extracellular amino acids (AAs) is at least in part mediated by the heterodimeric T1R1/T1R3, a G protein-coupled receptor. We show here that AAs differentially activate these two signaling pathways in MIN6 cells. Pretreatment with pertussis toxin did not prevent the activation of either ERK1/2 or mTORC1 by AAs, indicating that G(I) is not central to either pathway. Although glucagon-like peptide 1, an agonist for a G(s-)coupled receptor, activated ERK1/2 well and mTORC1 to a small extent, AAs had no effect on cytosolic cAMP accumulation. Ca(2+) entry is required for ERK1/2 activation by AAs but is dispensable for AA activation of mTORC1. Pretreatment with UBO-QIC, a selective G(q) inhibitor, reduced the activation of ERK1/2 but had little effect on the activation of mTORC1 by AAs, suggesting a differential requirement for G(q). Inhibition of G(12/13) by the overexpression of the regulator of G protein signaling domain of p115 ρ-guanine nucleotide exchange factor had no effect on mTORC1 activation by AAs, suggesting that these G proteins are also not involved. We conclude that AAs regulate ERK1/2 and mTORC1 through distinct signaling pathways.

Indexed as

Signal TransductionAmino AcidsAnimalsCalciumCyclic AMPEndosomesGene Expression RegulationHeLa CellsHumansInsulin-Secreting CellsLysosomesMechanistic Target of Rapamycin Complex 1MiceMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Multiprotein ComplexesAmino AcidsCalciumCyclic AMPMAPK1 protein, humanMapk1 protein, mouseMechanistic Target of Rapamycin Complex 1Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Multiprotein ComplexesReceptors, G-Protein-Coupledtaste receptors, type 1TOR Serine-Threonine Kinases

Identifiers

PMID26168033
PMCPMC4517997
OpenAlexW1954294875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.